Sopharma AD (BUL:SFA)

Sopharma AD Ratios and Metrics

Market cap in millions BGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,238	958	910	541	556	402
Market Cap Growth	-7.00%	5.26%	68.20%	-2.70%	38.17%	-5.99%
Enterprise Value	1,764	1,356	1,316	841	889	800
Last Close Price	2.48	1.91	1.83	1.13	1.13	0.81
PE Ratio	14.74	12.31	9.48	7.61	6.21	13.50
Forward PE	-	11.25	11.25	11.25	11.25	11.25
PS Ratio	0.55	0.45	0.48	0.32	0.35	0.28
PB Ratio	1.39	1.13	1.21	0.76	0.84	0.71
P/TBV Ratio	2.08	1.70	1.34	0.83	0.96	0.84
P/FCF Ratio	7.34	22.15	44.09	5.96	-	-
P/OCF Ratio	6.09	12.51	20.21	4.92	-	-
EV/Sales Ratio	0.78	0.63	0.70	0.50	0.55	0.55
EV/EBITDA Ratio	10.23	12.01	10.29	7.07	9.47	10.79
EV/EBIT Ratio	14.92	17.77	14.10	9.80	14.45	18.46
EV/FCF Ratio	10.46	31.35	63.74	9.27	-	-
Debt / Equity Ratio	0.62	0.56	0.47	0.40	0.50	0.75
Debt / EBITDA Ratio	3.93	3.59	2.41	2.10	2.95	4.84
Debt / FCF Ratio	3.26	11.10	17.00	3.12	-	-
Asset Turnover	1.27	1.29	1.37	1.36	1.32	1.20
Inventory Turnover	4.30	4.24	4.76	4.89	4.65	4.37
Quick Ratio	0.63	0.52	0.70	0.66	0.70	0.56
Current Ratio	1.24	1.17	1.29	1.41	1.35	1.12
Return on Equity (ROE)	11.17%	10.28%	13.59%	11.10%	14.97%	4.43%
Return on Assets (ROA)	3.01%	2.88%	4.21%	4.37%	3.14%	2.24%
Return on Capital (ROIC)	4.07%	3.92%	5.54%	5.39%	3.88%	2.73%
Return on Capital Employed (ROCE)	7.50%	7.10%	10.30%	10.10%	7.90%	6.20%
Earnings Yield	7.15%	8.13%	10.55%	13.14%	16.09%	7.41%
FCF Yield	13.62%	4.52%	2.27%	16.77%	-17.32%	-50.43%
Dividend Yield	2.01%	-	18.00%	17.76%	-	-
Payout Ratio	190.42%	216.37%	74.90%	0.01%	0.07%	75.97%
Buyback Yield / Dilution	-24.34%	-19.22%	-10.64%	0.36%	0.31%	0.11%
Total Shareholder Return	-22.34%	-19.22%	7.36%	18.13%	0.31%	0.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.